I think they painted as bleak a picture as possible. One BIG reason for this is to avoid suits. While they mentioned compitition they did not say if we are ahead of them. There was no rah rah involved and I take that as a good sign. Just one man's opinion. Lou
Hi all, first Happy New Year, it is gonna do its own thing anyway..lol.
goldhaunter--i am not very good on patents but i have talked to Celsion several times, and have been assured that they are solid. Dr. Fenn has been down this road before i am assured. beyond that, one of our memebers on Raging Bull ye3365 (i think) early in the game on RB provided extensive analysis for us on the patent stuff.. try around posts 60 or so. of course they are posted on the unofficial Celsion DD page.
this is something Tim Sullivan and i set up last year, but i havent talked to him in some time..(better do that..new years resolution..) ------
not a gonna comment on bsmd..been there done that more times than i can count..suffice to say there is a difference between phased array and adaptive phased array. ------------------
on Sec filing 12.28.. Lou, i think essentially your correct. the filings of most stocks in this stage, are pretty boilerplate, to cover any and all possible contingencies to include but not limited to, the sky is falling.
here is one item from the filing.. i can forsee another horse race again for funding..8 million to spend this year, and 8+ million in the bank. tis my hope that by the end of the year we can be to market, or close enough that the stock price will reflect its value. goodness only knows what else is up their sleeve, but i do believe that down the road the liposome of duke will be the vein of gold. to reach that i assume from their filings that we will partner with the drug firms.. this is a long way to play out, but it would not surprise me at all if they have not had/or will make preliminary coffee and teas with such companies.
take care.. hang on i think..twill be a couple of years probably. these danged things always take twice as long as estimated.
****We currently plan to expend approximately $8.0 million in the fiscal year ending September 30, 2001, and currently have available a total of approximately $8.8 million for that purpose. It is our current intention both to increase the pace of development work on our present products and to make a significant commitment to thermosensitive liposome and gene therapy research and development projects. The increase in the scope of present development work and the commitment to these new projects will require additional external funding, at least until we are able to begin marketing our products.
Thanks for the response. After I thought about it, I remembered Edgar filings are usually pretty reserved. Sorry for the moment of hesitation. The legalese of patent law is not something I feel very comfortable with, so that was just for elaboration. Happy New Year all.